Novo Integrated Sciences (NVOS)
(Real Time Quote from BATS)
$0.73 USD
-0.09 (-10.86%)
Updated Jun 20, 2024 03:54 PM ET
After-Market: $0.73 0.00 (0.00%) 4:10 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Novo Integrated Sciences, Inc falls in the month of August .
All items in Millions except EPS data.
8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 | |
---|---|---|---|---|---|
Sales | 13 | 12 | 9 | 8 | 9 |
Cost Of Goods | 8 | 7 | 5 | 5 | 6 |
Gross Profit | 5 | 5 | 4 | 3 | 4 |
Selling & Adminstrative & Depr. & Amort Expenses | 14 | 30 | 8 | 7 | 4 |
Income After Depreciation & Amortization | -9 | -25 | -4 | -4 | -1 |
Non-Operating Income | -4 | -6 | 0 | -1 | 1 |
Interest Expense | 0 | 2 | 0 | 0 | 0 |
Pretax Income | -13 | -33 | -4 | -5 | 0 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -13 | -33 | -4 | -5 | 0 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -13 | -33 | -4 | -5 | 0 |
Depreciation Footnote | 8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -2 | -16 | -3 | -3 | -1 |
Depreciation & Amortization (Cash Flow) | 7 | 9 | 2 | 1 | 0 |
Income After Depreciation & Amortization | -9 | -25 | -4 | -4 | -1 |
Earnings Per Share Data | 8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 |
---|---|---|---|---|---|
Average Shares | 10.17 | 2.91 | 2.48 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.83 | -10.00 | -1.80 | NA | NA |
Diluted Net EPS (GAAP) | -1.30 | -11.30 | -1.80 | -0.20 | NA |
Fiscal Year end for Novo Integrated Sciences, Inc falls in the month of August .
All items in Millions except EPS data.
5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | |
---|---|---|---|---|---|
Sales | NA | 3.17 | 3.89 | 3.30 | 3.29 |
Cost Of Goods | NA | 1.85 | 1.95 | 2.38 | 1.98 |
Gross Profit | NA | 1.32 | 1.94 | 0.93 | 1.31 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.86 | 5.26 | 4.02 | 2.74 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.54 | -3.32 | -3.09 | -1.43 |
Non-Operating Income | NA | -1.07 | -1.20 | -0.05 | -0.05 |
Interest Expense | NA | 0.14 | 0.14 | 0.06 | 0.01 |
Pretax Income | NA | -2.75 | -4.66 | -3.20 | -1.49 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.02 | -0.04 | 0.01 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -2.75 | -4.66 | -3.20 | -1.49 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.75 | -4.68 | -3.16 | -1.50 |
Earnings Per Share Data | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 17.64 | 16.73 | NA | 14.36 |
Diluted EPS Before Non-Recurring Items | NA | -0.16 | -0.28 | NA | -0.10 |
Diluted Net EPS (GAAP) | NA | -0.16 | -0.28 | 0.60 | -0.10 |